[3] The combination of potent weight loss and glucose control underscores retatrutides potential as a dual-purpose treatment for metabolic disorders, addressing both adiposity and insulin resistance in a single medication
The handout is easy to follow and designed with real-life eating in mind
GLP-1 medications often lead to weight loss of 1525% within the first year, with most people reaching their peak loss around 36 weeks
Our providers bring extensive experience in medical weight loss, honest assessment of candidacy and expectations, ongoing monitoring and dosing adjustments, and immediate support if concerns arise
Roeder HA, Moore TR, Ramos GA (2016) Changes in postpartum insulin requirements for patients with well-controlled type 1 diabetes
Novo Nordisk) and tirzepatide (Mounjaro, Eli Lilly & Co.)